Literature DB >> 8311658

Diffuse axonal injury in craniocerebral trauma. A comparative histologic and immunohistochemical study.

S H Gultekin1, T W Smith.   

Abstract

Axonal swellings are the major histologic hallmark of diffuse axonal injury in craniocerebral trauma. In this study, we compared conventional histologic and immunohistochemical methods for demonstrating axonal swellings in 11 cases of head trauma. Brain regions known to be susceptible to diffuse axonal injury were examined with conventional hematoxylin-eosin and silver (Bodian) stains and immunohistochemical markers for neurofilaments, ubiquitin, and tau and beta/A4-amyloid. A quantitative assessment of the axonal swellings visualized with each stain was made. In all but one case, axonal swellings were identified with the hematoxylin-eosin stain. By contrast, both the silver and neurofilament stains demonstrated fewer axonal swellings and were often difficult to interpret due to staining of normal axons. In the majority of cases, the ubiquitin stain revealed the greatest number of axonal swellings. Axonal swellings were not visualized with the tau or beta/A4-amyloid antibodies. We conclude that the standard hematoxylin-eosin stain remains a reliable method for the detection of axonal swellings in craniocerebral trauma and is superior to the Bodian and neurofilament stains. Identification and quantitative assessment of diffuse axonal injury is aided by the use of immunocytochemical staining for ubiquitin.

Entities:  

Mesh:

Year:  1994        PMID: 8311658

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  12 in total

Review 1.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

2.  A jugular vein compression collar prevents alterations of endogenous electrocortical dynamics following blast exposure during special weapons and tactical (SWAT) breacher training.

Authors:  Scott Bonnette; Jed A Diekfuss; Adam W Kiefer; Michael A Riley; Kim D Barber Foss; Staci Thomas; Christopher A DiCesare; Weihong Yuan; Jonathan Dudley; Amit Reches; Gregory D Myer
Journal:  Exp Brain Res       Date:  2018-07-10       Impact factor: 1.972

3.  Mild traumatic brain injury: longitudinal regional brain volume changes.

Authors:  Yongxia Zhou; Andrea Kierans; Damon Kenul; Yulin Ge; Joseph Rath; Joseph Reaume; Robert I Grossman; Yvonne W Lui
Journal:  Radiology       Date:  2013-03-12       Impact factor: 11.105

Review 4.  Chronic neuropathologies of single and repetitive TBI: substrates of dementia?

Authors:  Douglas H Smith; Victoria E Johnson; William Stewart
Journal:  Nat Rev Neurol       Date:  2013-03-05       Impact factor: 42.937

5.  Expression of ubiquitin-like immunoreactivity in axons after compression trauma to rat spinal cord.

Authors:  G L Li; M Farooque
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

6.  Acute reduction of microglia does not alter axonal injury in a mouse model of repetitive concussive traumatic brain injury.

Authors:  Rachel E Bennett; David L Brody
Journal:  J Neurotrauma       Date:  2014-07-16       Impact factor: 5.269

7.  Small world properties changes in mild traumatic brain injury.

Authors:  Yongxia Zhou
Journal:  J Magn Reson Imaging       Date:  2016-11-30       Impact factor: 4.813

8.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

9.  Markers of axonal injury in post mortem human brain.

Authors:  F E Sherriff; L R Bridges; S M Gentleman; S Sivaloganathan; S Wilson
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Axonal injury: a universal consequence of fatal closed head injury?

Authors:  S M Gentleman; G W Roberts; T A Gennarelli; W L Maxwell; J H Adams; S Kerr; D I Graham
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.